77
Table 3.1: Considered tripeptide-tissue pairs by using the rule (3.35) with a threshold
value of 7. The expected values of FDR and FNR are 0.337 and 0.113 respectively.
Pairs considered: 30.
|
Tissue |
Tripeptide |
Stage 1 |
Stage 2 |
Stage 3 |
mi |
Pi |
|
BM |
AAR |
2 |
6 |
96 |
12.19 |
0.56 |
|
BM |
FGI |
0 |
2 |
12 |
7.90 |
0.63 |
|
BM |
FGR |
3 |
11 |
101 |
18.17 |
0.96 |
|
BM |
GFR |
5 |
8 |
110 |
15.51 |
0.76 |
|
BM |
GGH |
3 |
4 |
70 |
10.97 |
0.53 |
|
BM |
GGM |
5 |
13 |
72 |
15.32 |
0.98 |
|
BM |
GWG |
4 |
6 |
72 |
15.69 |
0.82 |
|
BM |
GWS |
1 |
3 |
21 |
11.59 |
0.76 |
|
BM |
QGS |
0 |
3 |
15 |
10.15 |
0.77 |
|
BM |
QGW |
0 |
2 |
13 |
9.10 |
0.66 |
|
BM |
RPR |
0 |
1 |
13 |
9.14 |
0.54 |
|
BM |
RTS |
2 |
5 |
25 |
9.14 |
0.79 |
|
F |
ARF |
5 |
4 |
101 |
7.41 |
0.33 |
|
F |
FGR |
8 |
4 |
102 |
8.39 |
0.41 |
|
F |
GFR |
6 |
15 |
107 |
17.36 |
0.99 |
|
F |
GGM |
5 |
4 |
64 |
12.70 |
0.66 |
|
F |
GHG |
0 |
4 |
60 |
11.13 |
0.51 |
|
F |
GRM |
4 |
5 |
103 |
9.18 |
0.42 |
|
F |
GWG |
2 |
6 |
62 |
16.66 |
0.87 |
|
F |
HGW |
2 |
4 |
61 |
12.31 |
0.60 |
|
MU |
GFR |
7 |
12 |
171 |
15.97 |
0.78 |
|
MU |
GGM |
4 |
7 |
104 |
14.02 |
0.68 |
|
MU |
SRT |
0 |
3 |
13 |
7.46 |
0.70 |
|
PR |
ARF |
0 |
1 |
21 |
8.50 |
0.42 |
|
PR |
ARR |
4 |
3 |
44 |
11.92 |
0.66 |
|
PR |
GHG |
0 |
1 |
16 |
9.20 |
0.49 |
|
PR |
HGW |
0 |
1 |
16 |
9.38 |
0.50 |
|
SK |
DVR |
2 |
2 |
20 |
8.10 |
0.60 |
|
SK |
GFR |
9 |
30 |
183 |
17.34 |
1.00 |
|
SK |
RLR |
2 |
1 |
20 |
8.24 |
0.50 |
More intriguing information
1. The quick and the dead: when reaction beats intention2. Dual Track Reforms: With and Without Losers
3. Manufacturing Earnings and Cycles: New Evidence
4. The name is absent
5. Large Scale Studies in den deutschen Sozialwissenschaften:Stand und Perspektiven. Bericht über einen Workshop der Deutschen Forschungsgemeinschaft
6. Activation of s28-dependent transcription in Escherichia coli by the cyclic AMP receptor protein requires an unusual promoter organization
7. Concerns for Equity and the Optimal Co-Payments for Publicly Provided Health Care
8. ENERGY-RELATED INPUT DEMAND BY CROP PRODUCERS
9. Tariff Escalation and Invasive Species Risk
10. The name is absent